doi.org/10.1016/s1470-2045(20)30599-4
Other

Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial

..., Patrick Rat
31
The Lancet Oncology41.60
Volume: 22, Issue: 2, Pages: 256 - 266
Published: Jan 19, 2021
Paper Fields
Paper Details
Title
Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy versus cytoreductive surgery alone for colorectal peritoneal metastases (PRODIGE 7): a multicentre, randomised, open-label, phase 3 trial
DOI
doi.org/10.1016/s1470-2045(20)30599-4
Published Date
Jan 19, 2021
Journal
The Lancet Oncology
Volume
22
Issue
2
Pages
256 - 266
© 2025 Pluto Labs All rights reserved.